Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized, placebo-controlled, blinded study of vedolizumab in moderate to severe Crohn's disease
2008-002783-33Phase 3Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Oct 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Vedolizumab induction with Placebo (2 arms). Primary endpoint: Primary induction endpoint. Started Oct 2008; status: completed.
02
Drugs
vedolizumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2008-002783-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002783-33.